Search Results 261-270 of 17300 for hba1c

1. A Study To Evaluate The Safety And Effectiveness Of Bimagrumab On Improvement In Total Lean Body Mass And Physical Performance Following Surgical Treatment Of Hip Fracture. - Mayo Clinic

   ... HbA1C ≥ 8% or average blood glucose ≥ 9.0 mmol/l); Significant coagulopathy, platelet count less than 75,000/mm3, or anemia (hemoglobin less than 8.0 g/dL) ...

2. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

   8. Diabetes mellitus requiring insulin or insulin secretagogue therapy. 9. Poorly controlled diabetes mellitus defined as glycosylated hemoglobin A1c (HbA1c) > ...

3. Diabetes - Doctors and departments - Mayo Clinic

   Learn more about the different types of this blood sugar disorder, who's at risk and how each type can be treated.

4. Type 1 diabetes - Doctors and departments - Mayo Clinic

   Learn about the symptoms, causes, treatment of this chronic condition in which the pancreas produces little or no insulin.

5. Publications - Leslie J. Donato, Ph.D. - Mayo Clinic

   Reportable ranges for HbA1c test. MLO Med Lab Obs. 2011 Sep; 43(9):31-3. Stevens MJ, Donato LJ, Lower SK, Sahai N. Oxide-dependent adhesion of the Jurkat ...

6. A Study Assessing The Effectiveness And Safety Of Alpelisib + Nab-paclitaxel In Subjects With Advanced Triple Negative Breast Cancer - Mayo Clinic

   Subject with an established diagnosis of diabetes mellitus type I or uncontrolled type II based on Fasting Plasma Glucose and HbA1c. Subject has impairment ...

7. Publications - Marcus Vinicius R. Pinto, M.D., M.S. - Mayo Clinic

   HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes. Diabetol Metab Syndr. 2020; 12:85 ...

8. Circulating Nucleic Acid Based Biomarkers For Early Detection Of Hepatocellular Carcinoma (HCC) - Mayo Clinic

   The goals of this study are to establish the role of circulating nucleic acid based biomarkers in early diagnosis, prognosis or treatment response in human ...

9. Study Of Safety And Efficacy Of Dapagliflozin + Metformin XR Versus Metformin XR In Participants With HR+, HER2-, Advanced Breast Cancer While On Treatment With Alpelisib And Fulvestrant - Mayo Clinic

   Participants with an established diagnosis of diabetes mellitus type I or participants with uncontrolled type II diabetes mellitus (FPG > 160 mg/dL and/or HbA1c ...

10. Clinical Trial Enzyme Application Targeting Venous Leg Ulcers - Mayo Clinic

    HbA1c > 8.5% at screening. Significant hepatic impairment as defined by screening LFTs of AST and ALT > 3 times upper limit of normal (1 retest allowed) ...